0001735054-18-000001.txt : 20180410 0001735054-18-000001.hdr.sgml : 20180410 20180410164113 ACCESSION NUMBER: 0001735054-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180410 DATE AS OF CHANGE: 20180410 EFFECTIVENESS DATE: 20180410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RED OAK MEDICINES INC. CENTRAL INDEX KEY: 0001735054 IRS NUMBER: 822371405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309796 FILM NUMBER: 18748402 BUSINESS ADDRESS: STREET 1: 21 STRATHMORE ROAD CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: 847-232-7226 MAIL ADDRESS: STREET 1: 21 STRATHMORE ROAD CITY: NATICK STATE: MA ZIP: 01760 D 1 primary_doc.xml X0708 D LIVE 0001735054 RED OAK MEDICINES INC. 21 STRATHMORE ROAD NATICK MA MASSACHUSETTS 01760 847-323-7226 DELAWARE Red Oak Medicinal Inc. None Corporation true 2017 Hongtao Li c/o Red Oak Medicines Inc. 21 Strathmore Road Natick MA MASSACHUSETTS 01760 Executive Officer Director President and Director Yong Wang c/o Red Oak Medicines Inc. 21 Strathmore Road Natick MA MASSACHUSETTS 01760 Director Michael Franken c/o Red Oak Medicines Inc. 21 Strathmore Road Natick MA MASSACHUSETTS 01760 Executive Officer Chief Executive Officer David Scadden, MD c/o Red Oak Medicines Inc. 21 Strathmore Road Natick MA MASSACHUSETTS 01760 Director Walter Huang c/o Red Oak Medicines Inc. 21 Strathmore Road Natick MA MASSACHUSETTS 01760 Executive Officer Secretary and Director Pharmaceuticals Decline to Disclose 06b false 2017-11-20 true true true true true Equity securities consisting of Series A Preferred Stock, and underlying shares of common stock. false 0 5100000 2100000 3000000 Initial closing for issuance of 40,000,000 Series A Preferred shares; remaining purchase price of $3,000,000 in payment of 3,000,000 shares of Series A Preferred after achieving Milestone event. false 4 0 0 0 false RED OAK MEDICINES INC. /s/ Hongtao Li Hongtao Li President 2018-04-06